» Articles » PMID: 31929891

Alarming Endoscopic Data in Young and Older Asymptomatic People: Results of an Open Access, Unlimited Age Colonoscopic Screening for Colorectal Cancer

Abstract

There is a lack of a national organized screening program for colorectal cancer in Greece, and asymptomatic detection is usually the result of individual decisions. The collection of epidemiologic endoscopic data from a population of interest would therefore provide valuable information for future treatment guidance, especially during periods of economic austerity. The current cross-sectional study included 380 asymptomatic, average risk individuals undergoing screening colonoscopy for the first time, during the period of one year in a tertiary public hospital in Athens. Descriptive and analytic epidemiologic data were analyzed. The prevalence of adenomas and advanced lesions were compared between the younger and older cohort, and a regression model was applied for risk evaluation. The mean age of participants was 63 years, and 53% were male. A significant proportion of patients presented with polyps (51.5%) and 25% of them had lesions in the proximal colon. The prevalence of adenomas and advanced adenomas was 29.5 and 11.8%, respectively. Similar high prevalence rates of lesions were identified in the cohort of individuals <50 years of age and the older cohort (>50 years of age). Regression models identified age, number and size of polyps as the major risk factors for the detection of adenomas. The increase of advanced lesions in the older and younger cohort requires confirmation by larger studies. Overall, the results of the present study indicate the requirement for a well-organized screening colonoscopy program starting from as early as 40 years of age. This program may confer an additional endoscopic burden with socioeconomic consequences in a country with limited health resources.

Citing Articles

When Should Colon Cancer Screening Begin? The Impact of Early-Onset Colorectal Cancer and the Reality of an Unscreened Older Population.

Lansdorp-Vogelaar I, Rabeneck L Dig Dis Sci. 2024; .

PMID: 39724471 DOI: 10.1007/s10620-024-08738-6.


From the Friend to the Foe- Diverse Impact on the Human Immune System.

Daca A, Jarzembowski T Int J Mol Sci. 2024; 25(4).

PMID: 38397099 PMC: 10888668. DOI: 10.3390/ijms25042422.


Early-Age Onset Colorectal Neoplasia in Average-Risk Individuals Undergoing Screening Colonoscopy: A Systematic Review and Meta-Analysis.

Kolb J, Hu J, Desanto K, Gao D, Singh S, Imperiale T Gastroenterology. 2021; 161(4):1145-1155.e12.

PMID: 34119517 PMC: 8463452. DOI: 10.1053/j.gastro.2021.06.006.

References
1.
Lin J, Piper M, Perdue L, Rutter C, Webber E, OConnor E . Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2016; 315(23):2576-94. DOI: 10.1001/jama.2016.3332. View

2.
Skroumpelos A, Zavras D, Pavi E, Kyriopoulos J . Recommending organized screening programs for adults in Greece: a Delphi consensus study. Health Policy. 2012; 109(1):38-45. DOI: 10.1016/j.healthpol.2012.08.003. View

3.
Bokemeyer B, Bock H, Huppe D, Duffelmeyer M, Rambow A, Tacke W . Screening colonoscopy for colorectal cancer prevention: results from a German online registry on 269000 cases. Eur J Gastroenterol Hepatol. 2009; 21(6):650-5. DOI: 10.1097/meg.0b013e32830b8acf. View

4.
. The burden of disease in Greece, health loss, risk factors, and health financing, 2000-16: an analysis of the Global Burden of Disease Study 2016. Lancet Public Health. 2018; 3(8):e395-e406. PMC: 6079016. DOI: 10.1016/S2468-2667(18)30130-0. View

5.
Altobelli E, Lattanzi A, Paduano R, Varassi G, Di Orio F . Colorectal cancer prevention in Europe: burden of disease and status of screening programs. Prev Med. 2014; 62:132-41. DOI: 10.1016/j.ypmed.2014.02.010. View